BTI trades 32.1% above Wall Street's consensus target of $40.00.
Last 12 months price action with 12-month analyst target path
The base valuation assumes BTI achieves its forward estimates and maintains a stable P/E multiple of 16.5x. This scenario reflects the blended consensus of 18 Wall Street analysts, balancing both positive catalysts and macroeconomic headwinds over the next 12 months.
As of June 21, 2026, British American Tobacco p.l.c. (BTI) has a Wall Street consensus price target of $40.00, based on estimates from 18 covering analysts. With the stock currently trading at $58.91, this represents a potential downside of -32.1%. The company has a market capitalization of $127.75B.
Analyst price targets range from a low of $40.00 to a high of $40.00, representing a 0% spread in expectations. The median target of $40.00 aligns closely with the consensus average. The tight target dispersion indicates high conviction among analysts.
The current analyst consensus rating is Buy, with 12 analysts rating the stock as a Buy or Strong Buy,4 rating it Hold, and 2 rating it Sell or Strong Sell. The positive sentiment balance indicates moderate optimism about the stock prospects.
From a valuation perspective, BTI trades at a trailing P/E of 32.6x and forward P/E of 16.5x. Analysts expect EPS to grow +173.3% over the next year.
| Company | Market Cap | Price | Target | Upside Potential | Rating | Fwd P/E | Analysts |
|---|---|---|---|---|---|---|---|
MOAltria Group, Inc. | $115.6B | $69.12 | $71.83 | +3.9% | Buy | 12.2x | 26 |
PMPhilip Morris International Inc. | $278.0B | $178.40 | $189.60 | +6.3% | Buy | 21.3x | 25 |
TPBTurning Point Brands, Inc. | $1.6B | $82.02 | $128.33 | +56.5% | Buy | 57.4x | 13 |
UVVUniversal Corporation | $1.3B | $52.16 | — | — | Buy | 12.5x | 1 |
XXII22nd Century Group, Inc. | $2M | $4.64 | — | — | — | — | — |
STGSunlands Technology Group | $46M | $3.41 | — | — | — | — | — |
CRONCronos Group Inc. | $1.0B | $2.71 | $2.30 | -15.1% | Hold | 31.0x | 15 |
IIPRInnovative Industrial Properties, Inc. | $1.7B | $59.60 | $84.67 | +42.1% | Hold | 13.9x | 11 |
CGCCanopy Growth Corporation | $372M | $0.97 | $14.47 | +1396.1% | Hold | — | 26 |
ACBAurora Cannabis Inc. | $181M | $2.93 | $5.92 | +102.0% | Hold | — | 14 |
Quick answers to the most common questions about buying BTI stock.
BTI's consensus price target is $40, -32.1% below the current price of $58.91. The 18 analysts tracking BTI see downside risk at present valuations.
BTI has a consensus rating of "Buy" based on 18 Wall Street analysts. The rating breakdown is predominantly bullish, with 12 Buy/Strong Buy ratings. The consensus 12-month price target of $40 implies -32.1% downside from current levels.
With a forward P/E of 16.4945x, BTI trades at a relatively low valuation. The consensus target of $40 implies -32.1% move, suggesting the market may be pricing in risks.
The most bullish Wall Street analyst has a price target of $40 for BTI, while the most conservative target is $40. The consensus of $40 represents the median expectation. These targets typically reflect 12-month expectations.
BTI is well covered by analysts, with 18 analysts providing price targets and ratings. Of these, 0 have Strong Buy ratings, 12 have Buy ratings, 4 recommend Hold, and 2 have Sell or Strong Sell ratings. Higher analyst coverage generally indicates greater institutional interest and more reliable consensus estimates.
The 12-month BTI stock forecast based on 18 Wall Street analysts shows a consensus price target of $40, with estimates ranging from $40 (bear case) to $40 (bull case). The median consensus rating is "Buy".
BTI trades at a forward P/E ratio of 16.5x based on next-twelve-months earnings estimates compared to a trailing P/E of 32.6x. The lower forward P/E indicates analysts expect earnings growth. A forward P/E is useful for comparing valuations when earnings are expected to change significantly.
Analysts are cautious on BTI, with 2 Sell ratings and a price target of $40 (-32.1% from current price). The "Buy" consensus suggests careful evaluation before buying. This information is for educational purposes only. Always conduct your own research, consider your financial situation, and consult a financial advisor before making investment decisions.
BTI analyst price targets range from $40 to $40, a 0% tight range reflecting strong analyst consensus. Differences stem from varying assumptions about revenue growth, profit margins, competitive dynamics, and valuation multiples. The $40 consensus represents the middle ground.
Deep dive into BTI consensus models and risk factors.
DCF models, multiple analysis, and analyst estimates.
10-year return with dividends reinvested.
See how regular investing compounds over time.
Compare growth, multiples, and margins vs sector.